Owens & Minor Inc. (NYSE: OMI) stock soared 6.68% to trade at $7.39 in Friday's pre-market session, following the company's better-than-expected fourth quarter 2024 earnings results and the announcement of a potential sale process for its Products & Healthcare Services segment.
The healthcare logistics company reported adjusted earnings per share of $0.55 for the fourth quarter, beating the consensus estimate of $0.52. Owens & Minor's revenue of $2.70 billion also topped analysts' expectations of $2.69 billion.
In the earnings release, Owens & Minor revealed that it is actively engaged in "robust discussions regarding the potential sale of its Products & Healthcare Services segment." The company stated that this move aligns with its strategy to focus on its higher-growth and higher-margin Patient Direct segment.
For the full year 2025, Owens & Minor expects revenue in the range of $10.85 billion to $11.15 billion, adjusted EBITDA between $560 million and $590 million, and adjusted EPS of $1.60 to $1.85. The company's guidance excludes any impact from the potential sale of the Products & Healthcare Services segment or the previously announced acquisition of Rotech.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。